Key result
Novel regulators like microRNAs and microbiota emerge as promising targets for future obesity treatment.
Why the study?
To highlight the relevance of different mediators controlling adipose tissue activity through a review of the main players present in white and brown adipose tissues.
Systematic Review
This review highlights novel mediators, including microRNAs and microbiota, that regulate adipose tissue activity and represent promising future therapeutic targets for obesity.
Novel regulators require clinical validation before use; extends preclinical insights on microRNAs and microbiota in obesity.
Adipose tissue is a multifunctional organ that regulates many physiological processes such as energy homeostasis, nutrition, the regulation of insulin sensitivity, body temperature, and immune response. In this review, we highlight the relevance of the different mediators that control adipose tissue activity through a systematic review of the main players present in white and brown adipose tissues. Among them, inflammatory mediators secreted by the adipose tissue, such as classical adipokines and more recent ones, elements of the immune system infiltrated into the adipose tissue (certain cell types and interleukins), as well as the role of intestinal microbiota and derived metabolites, have been reviewed. Furthermore, anti-obesity mediators that promote the activation of beige adipose tissue, e.g., myokines, thyroid hormones, amino acids, and both long and micro RNAs, are exhaustively examined. Finally, we also analyze therapeutic strategies based on those mediators that have been described to date. In conclusion, novel regulators of obesity, such as microRNAs or microbiota, are being characterized and are promising tools to treat obesity in the future.
No takes yet. Share an insight, caveat, or question.
Gómez‐Hernández et al. (2024) conducted a systematic review in Obesity. Mediators controlling adipose tissue activity (e.g., adipokines, microbiota, myokines, microRNAs) was evaluated. Novel regulators of obesity, such as microRNAs or microbiota, are being characterized and represent promising tools to treat obesity in the future.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: